Log In
Print this Print this

Mutacin 1140 (MU1140)

  Manage Alerts
Collapse Summary General Information
Company Oragenics Inc.
DescriptionLantibiotic peptide targeting the bacterial cell wall component lipid II
Molecular Target Not applicable
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today